NHOC/NHOP作为PET/CT放射组学与机器学习预测NSCLC淋巴结转移的新型生物标志物:两中心回顾性研究
本研究基于两中心342例非小细胞肺癌患者的18F-FDG PET/CT数据,评估基线NHOC/NHOP预测淋巴结转移(LNM)的价值,并构建结合临床数据、NHOC/NHOP和PET放射组学的可解释机器学习模型。联合模型在训练集、内部测试集和外部测试集的AUC分别为0.852、0.822和0.885,对LNM预测显著优于临床和NHOC模型(p<0.05),对隐匿性淋巴结转移(ONM)在全数据集AUC为0.85。
要点
- NHOC是LNM的独立预测因子,优于经典PET参数。
- 联合模型预测LNM的AUC在训练集、内部和外部测试集分别为0.852、0.822、0.885。
- 联合模型预测ONM在全数据集AUC为0.85。
核心结论
- 研究建立了准确、可解释的机器学习模型用于NSCLC术前LNM和ONM预测。
- NHOC作为新型独立预测因子,优于经典PET参数。
研究设计与样本
- 两中心回顾性研究,纳入342例接受18F-FDG PET/CT的NSCLC患者。
- 数据分为训练集(n=188)、内部测试集(n=63)和外部测试集(n=91)。
- 使用LIFEx软件提取NHOC/NHOP和284个放射组学特征,经Z-score归一化和ComBat harmonization。
- 训练八种机器学习模型,最佳算法用于构建临床、NHOC/NHOP、放射组学及联合四种预测模型。
- 采用SHAP值解释模型贡献。
主要发现
- 关键独立预测因子为PD-L1值、病灶大小和新型生物标志物NHOC。
- 多层感知机分类器(MLP)模型获得最高AUC(0.82,95% CI: 0.69-0.92)。
- 联合模型预测LNM在训练集AUC 0.852、内部测试集AUC 0.822、外部测试集AUC 0.885,显著优于临床和NHOC模型(p<0.05)。
- 联合模型预测ONM在全数据集AUC为0.85。
- SHAP分析突出关键特征如GLCM_InverseVariance-PET和NGTDM_Strength-CT。
关键数值与推荐
- 联合模型预测LNM的AUC在训练集为0.852、内部测试集为0.822、外部测试集为0.885。
- 联合模型预测ONM在全数据集AUC为0.85。
- MLP模型最高AUC为0.82(95% CI: 0.69-0.92)。
- 联合模型显著优于临床和NHOC模型(p<0.05)。
临床怎么用
- 基于临床数据、NHOC/NHOP和PET放射组学的联合模型可用于NSCLC术前LNM和ONM预测。
- 研究开发了列线图和在线计算器,决策曲线分析证实其优越的净临床获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: NHOC and NHOP, defined as the normalized distances from peak uptake to tumour centroid and perimeter, are novel PET/CT metrics of tumour aggressiveness. This two-centre study assessed the baseline NHOC/NHOP for predicting lymph node metastasis (LNM) in non-small cell lung cancer (NSCLC), then developed and validated an interpretable machine learning model combining clinical data, NHOC/NHOP and PET radiomics for LNM and occult nodal metastasis (ONM) prediction. METHODS: 342 patients from two centres underwent 18F-FDG PET/CT scans, and data were divided into training (n = 188), internal (n = 63), and external (n = 91) sets. NHOC/NHOP and 284 radiomics features were initially extracted using LIFEx software. These features were normalized using Z-score and harmonized via ComBat. To avoid single algorithmic bias, eight machine-learning models were trained on the optimal radiomics features. The best-performing algorithm was employed to develop four predictive models including clinical, NHOC/NHOP, radiomics, and their combination. Shapley Additive Explanations (SHAP) values were used to interpret model contributions. RESULTS: Key independent predictors were PD-L1 value, lesion size and the novel biomarker NHOC, establishing the clinical model (PD-L1 and size) and the NHOC model. The multi-layer perceptron classifier (MLP) model achieved the highest Area Under the Curve (AUC) (0.82, 95% CI: 0.69-0.92). For LNM prediction, the combined model demonstrated superior performance across training (AUC 0.852), internal test (AUC 0.822), and external test (AUC 0.885) sets. It significantly outperformed clinical and NHOC models (p < 0.05). For ONM prediction, the combined model achieved the AUC (0.85) on the full datasets. SHAP analysis highlighted key features like GLCM_InverseVariance-PET and NGTDM_Strength-CT. A nomogram and online calculator were developed, with decision-curve analysis confirming superior net clinical benefit. CONCLUSION: This study established an accurate, interpretable machine learning model for preoperative prediction of LNM and ONM in NSCLC. NHOC emerged as a novel independent predictor with respect to classical PET parameters.
引用
- Huang Q, Mo J, Deng X, et al. NHOC/NHOP as novel biomarkers for predicting lymph node metastasis in NSCLC using PET/CT radiomics and machine learning: a two-center retrospective study. Eur J Nucl Med Mol Imaging. 2025. PMID: 41137928. doi:10.1007/s00259-025-07560-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。